All Pharma News
EMA committee recommends approval for CStone Pharma’s Cejemly in combo

EMA committee recommends approval for CStone Pharma’s Cejemly in combo
PHARMABIZ
05 Jun 2024
Share Share
EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC

EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC
PHARMACEUTICAL TECHNOLOGY
03 Jun 2024
Share Share
EMA CHMP Recommends Cejemly Approval As 1L NSCLC Treatment

EMA CHMP Recommends Cejemly Approval As 1L NSCLC Treatment
PR NEWSWIRE
01 Jun 2024
Share Share
CStone gets a win for sugemalimab in oesophageal cancer

CStone gets a win for sugemalimab in oesophageal cancer
Phil Taylor PHARMAPHORUM
03 Jan 2023
Share Share
EQRx receives MHRA marketing approval for sugemalimab

EQRx receives MHRA marketing approval for sugemalimab
John Pinching PHARMATIMES
21 Dec 2022
Share Share
CStone presents updated results of a registrational study of sugemalimab

CStone presents updated results of a registrational study of sugemalimab
PRNEWSWIRE
07 Aug 2022
Share Share
Pfizer PD-L1 partner explores sale: Bloomberg

Pfizer PD-L1 partner explores sale: Bloomberg
Angus Liu FIERCEPHARMA
14 Jul 2022
Share Share
CStone and Pfizer announce NMPA approval of sugemalimab in NSCLC

CStone and Pfizer announce NMPA approval of sugemalimab in NSCLC
ASIAONE
06 Jun 2022
Share Share
CStone announces first patient enrollment in U.S. in Phase 1 trial of CS5001

CStone announces first patient enrollment in U.S. in Phase 1 trial of CS5001
PRNEWSWIRE
30 Mar 2022
Share Share
EQRx adds armor to its discount checkpoint inhibitor submission

EQRx adds armor to its discount checkpoint inhibitor submission
Kyle Blankenship ENDPTS
18 Jan 2022
Share Share